ASSET | DATE | % RETURN |
---|---|---|
Envela (ELA) | 9/5/1991 - 12/29/1991 | 347.2% |
BioLife Solutions (BLFS) | 9/5/1991 - 12/29/1991 | 301.8% |
Biomerica (BMRA) | 9/5/1991 - 12/29/1991 | 233.04% |
CEL-SCI (CVM) | 9/5/1991 - 12/29/1991 | 185% |
STAAR Surgical (STAA) | 9/5/1991 - 12/29/1991 | 170.45% |
Abeona Therapeutics (ABEO) | 9/5/1991 - 12/29/1991 | 162.4% |
Plexus (PLXS) | 9/5/1991 - 12/29/1991 | 130.31% |
GT Biopharma (GTBP) | 9/5/1991 - 12/29/1991 | 121.74% |
Neonode (NEON) | 9/5/1991 - 12/29/1991 | 110% |
Veru (VERU) | 9/5/1991 - 12/29/1991 | 103.12% |
Educational Development (EDUC) | 9/5/1991 - 12/29/1991 | 100% |
LCI Industries (LCII) | 9/5/1991 - 12/29/1991 | 99.95% |
Thor Industries (THO) | 9/5/1991 - 12/29/1991 | 93.74% |
Brightstar Lottery (BRSL) | 9/5/1991 - 12/29/1991 | 74.49% |
Stryker (SYK) | 9/5/1991 - 12/29/1991 | 72.86% |
Bel Fuse A (BELFA) | 9/5/1991 - 12/29/1991 | 71.43% |
Heron Therapeuti (HRTX) | 9/5/1991 - 12/29/1991 | 71.11% |
National HealthCare (NHC) | 9/5/1991 - 12/29/1991 | 70.3% |
Vicor (VICR) | 9/5/1991 - 12/29/1991 | 69.59% |
CorVel (CRVL) | 9/5/1991 - 12/29/1991 | 69.49% |
PTC (PTC) | 9/5/1991 - 12/29/1991 | 68.89% |
American Shared Hospital Service (AMS) | 9/5/1991 - 12/29/1991 | 66.67% |
Celldex Therapeutics (CLDX) | 9/5/1991 - 12/29/1991 | 66% |
PulteGroup (PHM) | 9/5/1991 - 12/29/1991 | 63.85% |
United States Lime & Minerals (USLM) | 9/5/1991 - 12/29/1991 | 62.51% |